Published in Antimicrob Agents Chemother on August 06, 2012
Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C. Antivir Ther (2014) 0.89
Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing. PLoS One (2014) 0.82
Identification of the NS5B S282T resistant variant and two novel amino acid substitutions that affect replication capacity in hepatitis C virus-infected patients treated with mericitabine and danoprevir. Antimicrob Agents Chemother (2014) 0.80
Modelling the interaction between danoprevir and mericitabine in the treatment of chronic HCV infection. Antivir Ther (2015) 0.75
Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med (2011) 19.01
Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med (2011) 16.93
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology (2011) 8.95
Preliminary study of two antiviral agents for hepatitis C genotype 1. N Engl J Med (2012) 6.44
Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients. Hepatology (2007) 6.12
Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir. Gastroenterology (2007) 5.53
SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders. Gastroenterology (2007) 4.44
Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders. Hepatology (2012) 3.54
Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients. Hepatology (2009) 3.35
Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients. Hepatology (2008) 3.14
Rapid emergence of protease inhibitor resistance in hepatitis C virus. Sci Transl Med (2010) 2.82
Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro. J Biol Chem (2003) 2.82
Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study. Gastroenterology (2006) 2.78
Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C. Hepatology (2007) 2.37
In vitro resistance profile of the hepatitis C virus NS3/4A protease inhibitor TMC435. Antimicrob Agents Chemother (2010) 2.28
Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus. Hepatology (2011) 2.24
Phenotypic characterization of resistant Val36 variants of hepatitis C virus NS3-4A serine protease. Antimicrob Agents Chemother (2007) 1.66
Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy. Hepatology (2009) 1.54
Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication. Antivir Chem Chemother (2006) 1.49
Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients. J Hepatol (2008) 1.49
Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: a phase 1b multiple ascending dose study. J Hepatol (2011) 1.47
Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients. J Antimicrob Chemother (2008) 1.47
Selected replicon variants with low-level in vitro resistance to the hepatitis C virus NS5B polymerase inhibitor PSI-6130 lack cross-resistance with R1479. Antimicrob Agents Chemother (2008) 1.38
Characterization of the metabolic activation of hepatitis C virus nucleoside inhibitor beta-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) and identification of a novel active 5'-triphosphate species. J Biol Chem (2007) 1.30
RG7128 alone or in combination with pegylated interferon-α2a and ribavirin prevents hepatitis C virus (HCV) Replication and selection of resistant variants in HCV-infected patients. J Infect Dis (2010) 1.14
Virologic escape during danoprevir (ITMN-191/RG7227) monotherapy is hepatitis C virus subtype dependent and associated with R155K substitution. Antimicrob Agents Chemother (2011) 1.06
Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HIV-HCV-coinfected patients. Antivir Ther (2011) 0.89
Antiviral activity of danoprevir (ITMN-191/RG7227) in combination with pegylated interferon α-2a and ribavirin in patients with hepatitis C. J Infect Dis (2011) 0.85
HMG CoA reductase: a negatively regulated gene with unusual promoter and 5' untranslated regions. Cell (1984) 7.66
Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J (1992) 5.84
Wind-driven upwelling in the Southern Ocean and the deglacial rise in atmospheric CO2. Science (2009) 5.36
Phytochrome and Seed Germination. I. Temperature Dependence and Relative P(FR) Levels in the Germination of Dark-germinating Tomato Seeds. Plant Physiol (1967) 5.14
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
Equity of access to health care services: theory and evidence from the UK. Soc Sci Med (2001) 4.83
Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol (2000) 4.58
Attempt at deriving a formula for setting general practitioner fundholding budgets. BMJ (1994) 4.19
The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer (2004) 4.06
Allocating resources to health authorities: development of method for small area analysis of use of inpatient services. BMJ (1994) 3.88
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem (2001) 3.86
Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA (2001) 3.55
DNA finger printing by oligonucleotide probes specific for simple repeats. Hum Genet (1986) 3.41
Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis (1992) 3.30
Agriculture. Sustainable intensification in agriculture: premises and policies. Science (2013) 3.24
Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models. Health Technol Assess (2007) 3.04
The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell (1999) 2.97
The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer (1999) 2.89
IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity (2000) 2.74
Nucleotide sequence of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase, a glycoprotein of endoplasmic reticulum. Nature (1984) 2.66
Appearance of crystalloid endoplasmic reticulum in compactin-resistant Chinese hamster cells with a 500-fold increase in 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Proc Natl Acad Sci U S A (1982) 2.58
Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme. Cell (1985) 2.56
Phytochrome and Seed Germination. III. Action of Prolonged Far Red Irradiation on the Germination of Tomato and Cucumber Seeds. Plant Physiol (1967) 2.54
Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J Clin Invest (2001) 2.49
Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol (2001) 2.45
Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit Care Med (1993) 2.42
One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Br Med J (Clin Res Ed) (1982) 2.39
Missed appointments in general practice: retrospective data analysis from four practices. Br J Gen Pract (2001) 2.33
Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br J Cancer (1996) 2.28
An enzymic 'latch' on a global carbon store. Nature (2001) 2.27
The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance. Curr Top Microbiol Immunol (2002) 2.27
Src tyrosine kinase is a novel direct effector of G proteins. Cell (2000) 2.26
The effect of brief halothane anesthesia during daily gavage on complications and body weight in rats. Contemp Top Lab Anim Sci (2001) 2.25
Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet (1992) 2.22
Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet (2001) 2.22
Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer (1998) 2.20
Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis (1993) 2.19
Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res (2001) 2.15
Cyclin D1 and prognosis in human breast cancer. Int J Cancer (1996) 2.11
Infection control for home health. Infect Control Hosp Epidemiol (1990) 2.09
Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin Microbiol Rev (1998) 2.06
Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility. J Virol (1996) 2.03
Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ (2008) 2.03
Comparison of sensitivities to two commercially available tuberculin skin test reagents in persons with recent tuberculosis. Clin Infect Dis (1997) 2.02
Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol (2001) 2.01
Expression of the ERBB3 gene product in breast cancer. Br J Cancer (1992) 2.01
Insights into interfacial activation from an open structure of Candida rugosa lipase. J Biol Chem (1993) 1.99
Kinetic studies of Ca2+ binding and Ca2+ clearance in the cytosol of adrenal chromaffin cells. Biophys J (1997) 1.99
Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) (1981) 1.99
Amplification of the gene for 3-hydroxy-3-methylglutaryl coenzyme A reductase, but not for the 53-kDa protein, in UT-1 cells. J Biol Chem (1983) 1.98
Effects on the right ventricle, pulmonary vasculature, and carotid bodies of the rat of exposure to, and recovery from, simulated high altitude. Thorax (1973) 1.95
Fulvine and the pulmonary circulation. Thorax (1971) 1.94
latheo encodes a subunit of the origin recognition complex and disrupts neuronal proliferation and adult olfactory memory when mutant. Neuron (1999) 1.94
A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J Biol Chem (1997) 1.91
Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy. Clin Pharmacol Ther (2009) 1.90
Intracellular oligonucleotide hybridization detected by fluorescence resonance energy transfer (FRET). Nucleic Acids Res (1994) 1.88
Widespread distribution of a single drug rifampicin formulation of inferior bioavailability in South Africa. Int J Tuberc Lung Dis (2002) 1.87
Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism (2001) 1.87
The histopathology of 36 cases of plexogenic pulmonary arteriopathy. Histopathology (1990) 1.85
Arabidopsis consensus intron sequences. Plant Mol Biol (1996) 1.85
Aminorex and the pulmonary circulation. Thorax (1971) 1.83
Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technol Assess (2005) 1.83
Replantation. Br Med J (Clin Res Ed) (1983) 1.81
Prevalence of chronic fatigue and chemical sensitivities in Gulf Registry Veterans. Arch Environ Health (1999) 1.81
Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry (1983) 1.81
Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet (2003) 1.80
Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol Cell (2000) 1.77
Intraoperative photodynamic therapy for malignant mesothelioma. Ann Thorac Surg (1990) 1.77
Risk factors for ovarian cancer: a case-control study. Br J Cancer (1989) 1.76
An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics (2002) 1.73
Molecular cloning of 3-hydroxy-3-methylglutaryl coenzyme a reductase and evidence for regulation of its mRNA. Proc Natl Acad Sci U S A (1982) 1.72
Prevalence of HLA sensitization in female apheresis donors. Transfusion (1999) 1.70
A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation (1995) 1.70
Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc Natl Acad Sci U S A (2004) 1.69
Characterization of the nuclear export signal of human T-cell lymphotropic virus type 1 Rex reveals that nuclear export is mediated by position-variable hydrophobic interactions. Mol Cell Biol (1996) 1.69
Measuring the fate of plant diversity: towards a foundation for future monitoring and opportunities for urgent action. Philos Trans R Soc Lond B Biol Sci (2005) 1.68
Immunodetection of multiple species of retinoic acid receptor alpha: evidence for phosphorylation. Exp Cell Res (1992) 1.68
EXPERIMENTAL NEPHRITIS IN THE FROG : I. THE ANATOMICAL EVIDENCE OF DAMAGE. J Exp Med (1930) 1.68
Human papillomavirus types 16 and 18 in carcinomas of the penis from Brazil. Int J Cancer (1986) 1.67
Statin use is associated with reduced mortality in COPD. Eur Respir J (2006) 1.66
Proteinuria in obstructive sleep apnea. Kidney Int (2001) 1.66
Biological barriers to therapy with antisense and siRNA oligonucleotides. Mol Pharm (2009) 1.65
Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology (Berl) (1991) 1.65
Export of dissolved organic carbon from peatlands under elevated carbon dioxide levels. Nature (2004) 1.65
The risk of seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics (1996) 1.65
Increasing rate of deliberate self poisoning. BMJ (1994) 1.65
Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review. BJOG (2007) 1.64
Array-based DNA methylation profiling in follicular lymphoma. Leukemia (2009) 1.63
TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii. Parasite Immunol (1999) 1.63
Discontinuing antiepileptic drugs in children with epilepsy: a prospective study. Ann Neurol (1994) 1.63
Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene (2007) 1.62
Evaluation of the home pad test in the investigation of female urinary incontinence. Br J Obstet Gynaecol (1996) 1.62
Electron microscopy of Crotalaria pulmonary hypertension. Thorax (1969) 1.61
MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology (2009) 1.61
Technology Status Evaluation report. Colonoscopy preparations. May 2001. Gastrointest Endosc (2001) 1.61
Yeast chromatin. Preparation from isolated nuclei, histone composition and transcription capacity. Eur J Biochem (1973) 1.61
Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation. Transpl Infect Dis (2007) 1.61
Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization. Mol Cell Biol (1999) 1.60